• About us
    • Our Journey
    • Vision & Mission
    • Milestones
    • Message from Chairman’s Desk
    • Parsvnath Team
      • Board of Directors
      • Senior Management
    • Awards & Recognition
    • Certifications
      • Integrated Management System
      • Care Ratings
    • Associated Brands
    • Other Activities
      • As Contractor
  • Projects
    • Residential
      • Agra
      • Delhi
      • Dharuhera
      • Ghaziabad
      • Greater-Noida
      • Gurugram
      • Lucknow
      • Mohan Nagar
      • Moradabad
      • Noida
      • Panchkula
      • Panipat
      • Pune
      • Rajpura
      • Sahibabad
      • Sonepat
    • Townships
      • Derabassi
      • Dharuhera
      • Indore
      • Jaipur
      • Jodhpur
      • Karnal
      • Panipat
      • Rajpura
      • Rohtak
      • Saharanpur
      • Sonepat
      • Ujjain
    • Retail
      • Associated Brands
      • Agra
      • Bhiwadi
      • Dehradun
      • Delhi
        • Parsvnath Mall, Rohini
        • Projects With DMRC
          • Parsvnath Mall, Akshardham
          • Parsvnath Mall, Azadpur
          • Parsvnath Mall, Inderlok
          • Parsvnath Mall, Kashmere Gate
          • Parsvnath Mall, Seelampur
          • Parsvnath Mall, Welcome
          • Elegante Mall, Netaji Subhash Place
      • Faridabad
      • Ghaziabad
      • Greater Noida
      • Gurugram
      • Lucknow
      • Mohali
      • Mohan Nagar
      • Moradabad
      • Noida
      • Saharanpur
      • Sonepat
    • Offices
      • Associated Brands
      • Projects With DMRC
        • Parsvnath Mall, Pratap Nagar
        • Parsvnath Mall, Shahdara
      • 27, K.G. Marg
      • Parsvnath Capital Tower
    • IT Parks
      • IT Park , Sohna Road , Gurugram
    • SEZS
  • Investors
    • History
      • Incorporation
      • Share Capital
      • Dividend
    • Board & Committees of Directors
      • Director’s Profile
      • Composition of the Committees of Directors
    • Stock Information
      • Listing
    • Financials
      • Annual Reports
      • Quarterly Results
    • Information under Listing Regulations / Companies act 2013
      • Notice of Board Meeting
      • Shareholding Pattern
      • Disclosure of Events or Information
      • Annual Secretarial Compliance Report
      • Related Party Disclosures
      • Voting Results
      • Annual Returns
      • Newspaper Publication
      • Video recording of AGMs
      • Notice under Section 160 of Companies Act, 2013 (“The Act”)
      • Code of Practices and Procedures for Fair Disclosure of UPSI and Policy For Determination of Legitimate Purposes
      • Code of Conduct to regulate, monitor and report trading by Designated Persons and their immediate Relatives and Policy and Procedures for Inquiry in case of Leak or Suspected Leak of UPSI
      • Code of Conduct for Corporate Governance
      • Policy for Determining Material Subsidiaries
      • Business Responsibility Policy
      • Related Party Transaction Policy
      • Corporate Social Responsibility Policy
      • Dividend Distribution Policy
      • Familiarization Programs for Independent Directors
      • Nomination and Remuneration Policy
      • Vigil Mechanism/ Whistle Blower Policy
      • Terms & Conditions of Appointment of Independent Directors
      • IEPF
      • Subsidiary Companies
      • Listed Subsidiary Companies
      • Postal Ballot
      • General Meetings
      • Split / Sub-division of Equity Shares of the Company
      • Book Closure/Record Date
      • Investor Grievance Redressal Cell
      • KMPs Authorized for Determining Materiality of an Event
      • Archival Policy
      • Policy for Maintenance and Preservation of Documents
      • Policy for determination of Materiality of events
    • Information under erstwhile Listing Agreement
      • Corporate Governance
      • Other Filings
    • SEBI (SAST) Regulations, 2011
      • Disclosures of reasons for encumbrance of shares by Promoters
    • Transfer of Shares only in Dematerialised form
    • Investor Service Request Form
    • Company Presentation
  • Media
    • Marketing Communications
      • TVC
      • Advertisement/ Campaign
  • Career
    • Philosophy
    • Job Opening
  • Contact Us
    • Corporate & Registered Office
    • Branch Offices
    • Regional Offices
    • Feedback
  • About us
    • Our Journey
    • Vision & Mission
    • Milestones
    • Message from Chairman’s Desk
    • Parsvnath Team
      • Board of Directors
      • Senior Management
    • Awards & Recognition
    • Certifications
      • Integrated Management System
      • Care Ratings
    • Associated Brands
    • Other Activities
      • As Contractor
  • Projects
    • Residential
      • Agra
      • Delhi
      • Dharuhera
      • Ghaziabad
      • Greater-Noida
      • Gurugram
      • Lucknow
      • Mohan Nagar
      • Moradabad
      • Noida
      • Panchkula
      • Panipat
      • Pune
      • Rajpura
      • Sahibabad
      • Sonepat
    • Townships
      • Derabassi
      • Dharuhera
      • Indore
      • Jaipur
      • Jodhpur
      • Karnal
      • Panipat
      • Rajpura
      • Rohtak
      • Saharanpur
      • Sonepat
      • Ujjain
    • Retail
      • Associated Brands
      • Agra
      • Bhiwadi
      • Dehradun
      • Delhi
        • Parsvnath Mall, Rohini
        • Projects With DMRC
          • Parsvnath Mall, Akshardham
          • Parsvnath Mall, Azadpur
          • Parsvnath Mall, Inderlok
          • Parsvnath Mall, Kashmere Gate
          • Parsvnath Mall, Seelampur
          • Parsvnath Mall, Welcome
          • Elegante Mall, Netaji Subhash Place
      • Faridabad
      • Ghaziabad
      • Greater Noida
      • Gurugram
      • Lucknow
      • Mohali
      • Mohan Nagar
      • Moradabad
      • Noida
      • Saharanpur
      • Sonepat
    • Offices
      • Associated Brands
      • Projects With DMRC
        • Parsvnath Mall, Pratap Nagar
        • Parsvnath Mall, Shahdara
      • 27, K.G. Marg
      • Parsvnath Capital Tower
    • IT Parks
      • IT Park , Sohna Road , Gurugram
    • SEZS
  • Investors
    • History
      • Incorporation
      • Share Capital
      • Dividend
    • Board & Committees of Directors
      • Director’s Profile
      • Composition of the Committees of Directors
    • Stock Information
      • Listing
    • Financials
      • Annual Reports
      • Quarterly Results
    • Information under Listing Regulations / Companies act 2013
      • Notice of Board Meeting
      • Shareholding Pattern
      • Disclosure of Events or Information
      • Annual Secretarial Compliance Report
      • Related Party Disclosures
      • Voting Results
      • Annual Returns
      • Newspaper Publication
      • Video recording of AGMs
      • Notice under Section 160 of Companies Act, 2013 (“The Act”)
      • Code of Practices and Procedures for Fair Disclosure of UPSI and Policy For Determination of Legitimate Purposes
      • Code of Conduct to regulate, monitor and report trading by Designated Persons and their immediate Relatives and Policy and Procedures for Inquiry in case of Leak or Suspected Leak of UPSI
      • Code of Conduct for Corporate Governance
      • Policy for Determining Material Subsidiaries
      • Business Responsibility Policy
      • Related Party Transaction Policy
      • Corporate Social Responsibility Policy
      • Dividend Distribution Policy
      • Familiarization Programs for Independent Directors
      • Nomination and Remuneration Policy
      • Vigil Mechanism/ Whistle Blower Policy
      • Terms & Conditions of Appointment of Independent Directors
      • IEPF
      • Subsidiary Companies
      • Listed Subsidiary Companies
      • Postal Ballot
      • General Meetings
      • Split / Sub-division of Equity Shares of the Company
      • Book Closure/Record Date
      • Investor Grievance Redressal Cell
      • KMPs Authorized for Determining Materiality of an Event
      • Archival Policy
      • Policy for Maintenance and Preservation of Documents
      • Policy for determination of Materiality of events
    • Information under erstwhile Listing Agreement
      • Corporate Governance
      • Other Filings
    • SEBI (SAST) Regulations, 2011
      • Disclosures of reasons for encumbrance of shares by Promoters
    • Transfer of Shares only in Dematerialised form
    • Investor Service Request Form
    • Company Presentation
  • Media
    • Marketing Communications
      • TVC
      • Advertisement/ Campaign
  • Career
    • Philosophy
    • Job Opening
  • Contact Us
    • Corporate & Registered Office
    • Branch Offices
    • Regional Offices
    • Feedback
  • Home
  • /
  • Sez'S  / Sectors  / Biotechnology
  • About Us
  • Overview
    • SEZ in India
  • SEZ Team
    • Board of Directors
  • Locations
    • Locations Overview
    • Kochi, Kerala
    • Hyderabad, Andhra Pradesh
  • Notified SEZ’s
  • Sectors
    • IT-ITES
    • Biotechnology
  • Contact Us

Biotechnology

Biotechnology Industry Highlights

WHY INDIA?

  • Biotechnology is a collection of technologies that capitalize on the attributes of cells, and put biological molecules such as DNA and proteins to work for us.
  • A few of the biotechnologies that use cells and biological molecules find applications in:
    • Medicine
    • Agriculture
    • Food Processing
    • Industrial Manufacturing
    • Environmental Management
  • ‘New’ biotechnologies are:
    • Bio-processing Technology
    • Monoclonal Antibodies
    • Cell Culture: including Plant Cell, Insect Cell, and Mammalian Cell culture
    • Recombinant DNA Technology
    • Cloning
    • Molecular Cloning: including Cellular and Animal cloning
    • Protein Engineering
    • Biosensors
    • Nanobiotechnology
    • Microarrays: including DNA, Protein, Tissue, Whole-Cell, and Small-Molecular microarrays
    • Bioinformatics
  • The pharmaceutical industry, stands to benefit as much as other industries from off shoring opportunities since its real value lies not just in simple cost savings but also in the faster development of new compounds and a greater focus for sales and marketing organizations. Thus, the benefits could span across the entire value chain, from R&D through manufacturing and sales adding huge values, often several hundred million dollars.
  • Low labor costs also offer the prospect of more efficient and successful clinical trials which form a very high content of a new drug’s development cost and over two-thirds of the trials miss their deadlines because they cant recruit patients quickly enough. Substantial cost savings can result by broadening the base of patients and physicians to include lower-cost countries.
  • Data management and bioinformatics functions are rapidly going global, though the US and EU continue to carry out the higher-end functions of biostatistics and biometrics.
  • India is also the top spot for outsourcing R&D operations ranging from chemistry services to data management to clinical trials.
  • It is estimated that by the year 2010, the pharma industry in India has the potential to achieve Rs. 1,00,000 crores (US $2.2 billion) in revenues from formulations with bulk drug production at Rs. 25,000 crores (US $0.5 billion).
  • A number of Government of India sponsored/owned R&D organizations are active in conducting and facilitating relevant research in this sector viz. Indian Council of Medical Research (ICMR), Indian Council of Agricultural Research (ICAR), and Council of Scientific and Industrial Research (CSIR). Recently, the National Institute of Biologicals (NIB) was also established in New Delhi to conduct research, manufacturing and clinical studies.

WHY HYDERABAD, ANDHRA PRADESH?

  • Hyderabad is a significant IT and Pharma industry hub of India and it is also a renowned center of learning. Andhra has among the largest resource pool of qualified and trained scientists and engineers educated in several technical and engineering institutions spread throughout the state.
Search

Property Search

DISCLAIMER

Note: This website is in the process of being updated in the light of Real Estate (Regulation & Development) Act, 2016 and Rules made thereunder by the respective States ( hereinafter referred as 'RERA' ). By accessing this website, the viewer confirms that the information including brochures and marketing collaterals on this website are solely for informational purposes only. Nothing on this website, constitutes advertising, marketing, booking, selling or an offer for sale, or invitation to purchase a unit in any project by the Company in terms of RERA ( Except of Projects which don't come under RERA / Projects where RERA Registration has been done) . The Company or any officer shall not be liable for any consequence of any action taken by the viewer relying on such material/ information on this website.

  • About Us
  • Project
  • Investors
  • Media
  • NRI Section
  • Careers
  • Reviews
  • Privacy Policy
  • Contact Us

© Copyright 2025 Parsvnath Developers Ltd.

site by: Cross Section

Exit mobile version